Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
4.900
-0.060 (-1.21%)
At close: Oct 24, 2024, 4:00 PM
4.880
-0.020 (-0.41%)
After-hours: Oct 24, 2024, 5:11 PM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $333.60 million as of October 24, 2024. Its market cap has decreased by -72.82% in one year.
Market Cap
333.60M
Enterprise Value
26.93M
1-Year Change
-72.82%
Ranking
Category
Stock Price
$4.90
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has decreased from $1.07B to $333.60M, a decrease of -68.80%. That is a compound annual growth rate of -34.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 337.70M | -66.02% |
| Dec 29, 2023 | 993.90M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.98% |
| Jan 7, 2022 | 1.07B | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zura Bio | 313.77M |
| Kamada | 309.18M |
| ProQR Therapeutics | 308.75M |
| ADC Therapeutics | 308.43M |
| AC Immune | 307.70M |
| OraSure Technologies | 304.98M |
| Jasper Therapeutics | 303.31M |
| Cerus | 302.03M |